Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Clinical therapeutics - 46(2024), 2 vom: 09. Feb., Seite 176-180 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Malchair, Pierre [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4QWG6N8QKH |
|---|
| Anmerkungen: |
Date Completed 27.02.2024 Date Revised 16.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clinthera.2023.11.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365635618 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365635618 | ||
| 003 | DE-627 | ||
| 005 | 20240417232314.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinthera.2023.11.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1378.xml |
| 035 | |a (DE-627)NLM365635618 | ||
| 035 | |a (NLM)38072752 | ||
| 035 | |a (PII)S0149-2918(23)00459-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Malchair, Pierre |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.02.2024 | ||
| 500 | |a Date Revised 16.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Coronavirus infections | |
| 650 | 4 | |a Odds ratio | |
| 650 | 4 | |a Pandemics | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Survival analysis | |
| 650 | 7 | |a Hydroxychloroquine |2 NLM | |
| 650 | 7 | |a 4QWG6N8QKH |2 NLM | |
| 700 | 1 | |a Villoria, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Giol, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Jacob, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Carnaval, Thiago |e verfasserin |4 aut | |
| 700 | 1 | |a Videla, Sebastián |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical therapeutics |d 1984 |g 46(2024), 2 vom: 09. Feb., Seite 176-180 |w (DE-627)NLM012642290 |x 1879-114X |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2024 |g number:2 |g day:09 |g month:02 |g pages:176-180 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clinthera.2023.11.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2024 |e 2 |b 09 |c 02 |h 176-180 | ||